Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus

Physiological Research

Volumn 51, Issue 6, 2002, Pages 597-604

  Kalousova M ^a   Skrha J ^a   Zima, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Advanced glycation end products; Advanced oxidation protein products; Diabetes mellitus; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; GLUCOSE; HEMOGLOBIN A1C; PROTEIN DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; STATISTICS;

EID: 0036972669     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BAYNES JW, THORPE SR: Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
2. BIERHAUS A, HOFMANN MA, ZIEGLER R, NAWROTH PP: AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37: 586-600, 1998.
3. BUONCORE G, PERRONE S, LONGINI M, TERZUOLI L, BRACCI R: Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 47: 221-224, 2000.
4. BUONGIORNO AM, MORELLI S, SAGRATELLA E, CASTALDO P, DI VIRGILIO A, MAROCCIA E, RICCIARDI G, SCIULLO E, CARDELLI G, FALLUCCA F, SENSI M: Levels of advanced glycosylation end-products (AGE) in sera of pregnant diabetic women: comparison between type 1 and type 2 and gestational diabetes mellitus. Ann 1st Super Sanita 33: 375-378, 1997.
5. DAIMON M, ONO Y, SAITO T, YAMAGUCHI H, HIRATA A, OHNUMA H, IGARASHI M, EGUCHI H, MANAKA H, KATO T: Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy. Diabetes Care 22: 877-878, 1999.
6. DOLHOFER-BLIESENER R, LECHNER B, DEPPISCH R, RITZ E, GERBITZ KD: Immunological determination of advanced glycosylation end-products in human blood and urine. Nephrol Dial Transplant 10: 657-664, 1995.
7. FURTH A: Glycated proteins in diabetes. Br J Biomed Sci 54: 192-200, 1997.
8. HENLE T, DEPPISCH R, BECK W, HERGESELL O, HANSCH G, RITZ E: Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant 14: 1968-1975, 1999.
9. KALOUSOVÁ M, ZIMA T, TESAŘ, V, ŠKRHA J, ŠTÍPEK S: Determination of advanced glycation end-products and advanced oxidation protein products. Klin Biochem Metab 10: 11-16, 2002.
10. MAILLARD LC: Action des acides amines sur les sucres; formation des melaniodines par voie methodique. C R Acad Sci 154: 66-68, 1912.
11. MIYATA T, VAN YPERSELE DE STRIHOU C, KUROKAWA K, BAYNES JW: Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55: 389-399, 1999.
12. MIYATA T, KUROKAWA K, VAN YPERSELE DE STRIHOU C: Relevance of oxidative stress to long-term uremic complications. Kidney Int 58: S120-S125, 2000.
13. MUNCH G, GERLACH M, SIAN J, WONG A, RIEDERER P: Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann Neurol 44 (Suppl 1): S85-S88, 1998.
14. MUNCH G, KIES R, WESSEL A, RIEDERER P, BAHNER U, HEIDLAND A, NIWA T, LEMKE HD, SCHINZEL R: Determination of advanced glycation and products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 35: 669-677, 1997.
15. ODANI H, IIJIMA K, NAKATA M, MIYATA S, KUSUNOKI H, YASUDA Y, HIKI Y, IRIE S, MAEDA K, FUJIMOTO D: Identification of Nω-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes. Biochem Biophys Res Commun 285: 1232-6, 2001.
16. ROSEN P, NAWROTH PP, KING G, MOLLER W, TRITSCHLER HJ, PACKER L: The role of oxidative stress in the onset and progression of diabetes and its complications. Diabetes Metab Res Rev 17: 189-212, 2001.
17. SCHLEICHER ED, WAGNER E, NERLICH AG: Increased accumulation of the glycoxidation product Nω-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99: 457-468, 1997.
18. STITT AW, HE C, FRIEDMAN S, SCHER L, ROSSI P, ONG L, FOUNDS H, LI YM, BUCALA R, VLASSARA H: Elevated AGE-modified Apo B in sera of euglycemic, normolipidaemic patients with atherosclerosis: relation to tissue AGE. Mol Med 3: 617-627, 1997.
19. TURK Z, MESIC R, BENCO B: Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin Alc for the assessment of diabetic control. Clin. Chim. Acta 277: 159-170, 1998.
20. VLASSARA H: Recent progress in advanced glycation end products and diabetic complications. Diabetes 46: S19-25, 1997.
21. WAGNER Z, WITTMAN I, MAZAK I, SCHINZEL R, HEIDLAND A, KIENTSCH-ENGEL R, NAGY J: Nω-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis 38: 785-791, 2001.
22. WITKO-SARSAT V, FRIEDLANDER M, CAPEILLERE-BLANDIN C, NGUYEN-KHOA T, NGUYEN AT, ZINGRAFF J, JUNGERS P, DESCHAMPS-LATSCHA B: Advanced oxidation protein products as a novel marker of oxidative stress in uraemia. Kidney Int 49: 1304-1313, 1996.
23. WITKO-SARSAT V, FRIEDLANDER M, NGUYEN-KHOA T, CAPEILLERE-BLANDIN C, NGUYEN AH, CANTERLOUP S, DRAYER JM, JUNGERS P, DRUEKE T, DESCHAMPS-LATSCHA B: Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998.